Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fiserv Inc
FISV
|
+$1.28B |
| 2 |
Aon
AON
|
+$1.25B |
| 3 |
Willis Towers Watson
WTW
|
+$762M |
| 4 |
Fidelity National Information Services
FIS
|
+$571M |
| 5 |
Adobe
ADBE
|
+$565M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$962M |
| 2 |
Goldman Sachs
GS
|
+$814M |
| 3 |
GE Aerospace
GE
|
+$764M |
| 4 |
Nutrien
NTR
|
+$587M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.72% |
| 2 | Financials | 18.28% |
| 3 | Industrials | 12.84% |
| 4 | Technology | 11.99% |
| 5 | Communication Services | 11.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Vipshop
VIPS
$6.11B
| $2.44M | ﹤0.01% |
124,197
| – | – |
2021 Q3
16 quarters
|
|
152
AbbVie
ABBV
$497B
| $2.42M | ﹤0.01% |
10,473
| – | – |
2013 Q2
49 quarters
|
|
153
Pfizer
PFE
$162B
| $2.37M | ﹤0.01% |
93,014
-14,946
| -14% | -$369K |
2013 Q2
49 quarters
|
|
154
Abbott
ABT
$176B
| $2.32M | ﹤0.01% |
17,324
| – | – |
2013 Q2
49 quarters
|
|
155
Hewlett Packard
HPE
$93.4B
| $2.16M | ﹤0.01% |
87,754
-829
| -0.9% | -$18.3K |
2015 Q4
39 quarters
|
|
156
McDonald's
MCD
$167B
| $1.97M | ﹤0.01% |
6,475
-98
| -1% | -$29.8K |
2013 Q2
49 quarters
|
|
157
Parker-Hannifin
PH
$121B
| $1.9M | ﹤0.01% |
2,500
| – | – |
2013 Q2
49 quarters
|
|
158
NextEra Energy
NEE
$164B
| $1.78M | ﹤0.01% |
23,600
| – | – |
2013 Q2
49 quarters
|
|
159
Honeywell
HON
$66.4B
| $1.69M | ﹤0.01% |
8,508
| – | – |
2013 Q2
49 quarters
|
|
160
Coca-Cola
KO
$386B
| $1.59M | ﹤0.01% |
24,000
-635
| -3% | -$43.7K |
2013 Q2
49 quarters
|
|
161
Otis Worldwide
OTIS
$25.4B
| $1.52M | ﹤0.01% |
16,610
-2,710
| -14% | -$246K |
2020 Q2
21 quarters
|
|
162
Las Vegas Sands
LVS
$23.4B
| $1.52M | ﹤0.01% |
28,186
| – | – |
2022 Q3
12 quarters
|
|
163
Kaspi.kz JSC
KSPI
$18.5B
| $1.46M | ﹤0.01% |
17,826
+10,000
| +128% | +$876K |
2024 Q1
6 quarters
|
|
164
Trip.com Group
TCOM
$24.4B
| $1.45M | ﹤0.01% |
19,250
| – | – |
2022 Q4
11 quarters
|
|
165
Unilever
UL
$136B
| $1.42M | ﹤0.01% |
21,244
| – | – |
2013 Q2
49 quarters
|
|
166
Zhihu
ZH
$288M
| $1.4M | ﹤0.01% |
+276,897
| New | +$1.31M |
2025 Q3
0 quarters
|
|
167
Corteva
CTVA
$8.87B
| $1.39M | ﹤0.01% |
20,539
-422
| -2% | -$30.6K |
2019 Q2
25 quarters
|
|
168
Altria Group
MO
$120B
| $1.39M | ﹤0.01% |
21,000
| – | – |
2013 Q2
49 quarters
|
|
169
eBay
EBAY
$51B
| $1.28M | ﹤0.01% |
14,050
-50
| -0.4% | -$4.42K |
2013 Q2
49 quarters
|
|
170
3M
MMM
$83B
| $1.19M | ﹤0.01% |
7,696
-1,450
| -16% | -$224K |
2013 Q2
49 quarters
|
|
171
DuPont de Nemours
DD
$17.5B
| $1.18M | ﹤0.01% |
12,089
-300
| -2% | -$28.3K |
2013 Q2
49 quarters
|
|
172
Colgate-Palmolive
CL
$71.7B
| $1.12M | ﹤0.01% |
14,000
| – | – |
2013 Q2
49 quarters
|
|
173
Diageo
DEO
$49.3B
| $1.06M | ﹤0.01% |
11,077
-120
| -1% | -$12.6K |
2013 Q2
49 quarters
|
|
174
Truist Financial
TFC
$57B
| $956K | ﹤0.01% |
20,911
| – | – |
2013 Q2
49 quarters
|
|
175
Mercado Libre
MELI
$95.9B
| $916K | ﹤0.01% |
+392
| New | +$941K |
2025 Q3
0 quarters
|
|
Similar funds
Dodge & Cox's Q3 2025 Portfolio in Review
As of Q3 2025, Dodge & Cox held 225 positions worth $185B, up 4.1% from $178B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Dodge & Cox's Q3 2025 filing shows 6 new, 50 increased, 106 reduced and 6 closed positions. Its largest new stake was Aon: 3,464,683 shares worth $1.24B. The largest sale was Wells Fargo, an estimated $962M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.
- Dodge & Cox's largest Q3 2025 buy was Aon: 3,464,683 shares worth $1.24B.
- Dodge & Cox added most to Fiserv Inc in Q3 2025, an estimated $1.28B increase.
- Dodge & Cox's biggest Q3 2025 reduction was Wells Fargo, cutting an estimated $962M.
- Dodge & Cox fully exited Nutrien in Q3 2025, selling an estimated $587M.
- Dodge & Cox's ten largest holdings make up 28% of its $185B portfolio in Q3 2025.
- Dodge & Cox opened 6 new positions and closed 6 in Q3 2025.
- Dodge & Cox's portfolio value rose 4.1% quarter-over-quarter to $185B.
Based on Dodge & Cox's 13F filing for Q3 2025, filed 13 Nov 2025.